These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9832292

  • 1. N-acetyl-aspartyl-glutamic acid inhibits cellular recruitment and mediator release during the late allergen-induced nasal reaction.
    Miadonna A, Milazzo N, Salmaso C, Cottini M, Lorini M, Tedeschi A.
    Eur J Clin Pharmacol; 1998 Sep; 54(7):515-20. PubMed ID: 9832292
    [Abstract] [Full Text] [Related]

  • 2. Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours.
    Miadonna A, Milazzo N, Gibelli S, Salmaso C, Lorini M, Tedeschi A.
    Clin Exp Allergy; 1999 Jul; 29(7):941-9. PubMed ID: 10383595
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
    Wang D, Duyck F, Smitz J, Clement P.
    Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
    [Abstract] [Full Text] [Related]

  • 4. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH, Devalia JL, Rusznak C, Bagnall A, Sapsford RJ, Davies RJ.
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [Abstract] [Full Text] [Related]

  • 5. Modulation of allergen-induced nasal symptoms and mediator release by treatment with N-acetyl-aspartyl-glutamate (ZY15106).
    Miadonna A, Cottini M, Candiani C, Tedeschi A.
    Eur J Clin Pharmacol; 1994 Feb; 46(2):127-31. PubMed ID: 7518775
    [Abstract] [Full Text] [Related]

  • 6. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
    Aubier M, Neukirch C, Maachi M, Boucara D, Engelstätter R, Steinijans V, Samoyeau R, Dehoux M.
    Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
    [Abstract] [Full Text] [Related]

  • 7. Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis.
    Vancheri C, Mastruzzo C, Armato F, Tomaselli V, Magrì S, Pistorio MP, LaMicela M, D'amico L, Crimi N.
    J Allergy Clin Immunol; 2001 Nov; 108(5):703-8. PubMed ID: 11692092
    [Abstract] [Full Text] [Related]

  • 8. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH, Devalia JL, Duddle JM, Hamilton SA, Davies RJ.
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP, Bjerke T, Christensen MB, Skamling M, Peterson CG, Mygind N, Dahl R.
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
    Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R.
    J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
    [Abstract] [Full Text] [Related]

  • 13. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
    Ciprandi G, Tosca M, Ricca V, Passalacqua G, Riccio AM, Bagnasco M, Canonica GW.
    Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
    [Abstract] [Full Text] [Related]

  • 14. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A, Milazzo N, Miadonna A.
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [Abstract] [Full Text] [Related]

  • 15. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM, Mucha SM, Detineo M, Naclerio RM.
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [Abstract] [Full Text] [Related]

  • 16. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R.
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [Abstract] [Full Text] [Related]

  • 17. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen.
    Assanasen P, Baroody FM, Naureckas E, Naclerio RM.
    Clin Exp Allergy; 2001 Dec; 31(12):1913-22. PubMed ID: 11737044
    [Abstract] [Full Text] [Related]

  • 18. A preliminary evaluation of the effect of N-acetyl-aspartyl-glutamate on pollen nasal challenge as measured by rhinomanometry and symptomatology.
    Ghaem A.
    Allergy; 1987 Nov; 42(8):626-30. PubMed ID: 3425862
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N, Gupta A, Badorrek P, Koenen R, Mueller M, Pivovarova A, Hilbert J, Wetzel K, Hohlfeld JM, Wood C.
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [Abstract] [Full Text] [Related]

  • 20. [NAAGA and cromoglycate. A comparison in the treatment of seasonal allergic rhinitis].
    Datz B, Sieger C, Weibel MA.
    Laryngol Rhinol Otol (Stuttg); 1988 Jun; 67(6):300-3. PubMed ID: 3136279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.